Hofu, Japan

Kazuhisa Iwata

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhisa Iwata. Retrieved from https://idiyas.com/inventor/kazuhisa-iwata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuhisa Iwata: Innovator in Uricase Production

Introduction

Kazuhisa Iwata, an esteemed inventor from Hofu, Japan, has made significant contributions to biotechnology. With his groundbreaking work in DNA coding and the production of uricase, Iwata has paved the way for advancements in medical and environmental applications of enzymes.

Latest Patents

Kazuhisa Iwata holds a notable patent titled "DNA coding for uricase and process for producing uricase." This invention provides a DNA sequence coding for uricase derived from the genus Cellulomonas. Iwata's process utilizes a microorganism that carries recombinant DNA, facilitating the efficient production of uricase, an enzyme that plays a crucial role in the metabolism of uric acid.

Career Highlights

Iwata is affiliated with Kyowa Hakko Kogyo Co., Ltd., where he collaborates with other leading researchers in the field. His focus on innovative biotechnological solutions has positioned the company at the forefront of enzyme production.

Collaborations

Iwata has worked alongside accomplished colleagues, including Makoto Yagasaki and Shuichi Ishino. Their teamwork exemplifies the synergy between researchers and inventors, fostering an environment where breakthroughs in scientific research can flourish.

Conclusion

Kazuhisa Iwata's inventive spirit and dedication to research continue to influence the field of biotechnology. His patented work on uricase production represents a significant leap forward in harnessing microbial technology for practical applications. As the world becomes increasingly reliant on biotechnological innovations, Iwata's contributions will undoubtedly play a vital role in shaping the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…